Ocular Therapeutix Stock Technical Analysis
| OCUL Stock | USD 10.06 0.31 3.18% |
As of the 30th of November, Ocular Therapeutix holds the Risk Adjusted Performance of 0.0561, semi deviation of 2.92, and Coefficient Of Variation of 1585.31. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Ocular Therapeutix, as well as the relationship between them. Please check Ocular Therapeutix jensen alpha and downside variance to decide if Ocular Therapeutix is priced some-what accurately, providing market reflects its current price of 10.06 per share. Given that Ocular Therapeutix has jensen alpha of 0.2002, we recommend you to check out Ocular Therapeutix's recent market performance to make sure the company can sustain itself at a future point.
Ocular Therapeutix Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Ocular, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to OcularOcular |
Ocular Therapeutix Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 13.13 | Strong Buy | 8 | Odds |
Most Ocular analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Ocular stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Ocular Therapeutix, talking to its executives and customers, or listening to Ocular conference calls.
Ocular Therapeutix technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Ocular Therapeutix Technical Analysis
The output start index for this execution was ten with a total number of output elements of fifty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Ocular Therapeutix volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Ocular Therapeutix Trend Analysis
Use this graph to draw trend lines for Ocular Therapeutix. You can use it to identify possible trend reversals for Ocular Therapeutix as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Ocular Therapeutix price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Ocular Therapeutix Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Ocular Therapeutix applied against its price change over selected period. The best fit line has a slop of 0.03 , which means Ocular Therapeutix will continue generating value for investors. It has 122 observation points and a regression sum of squares at 27.88, which is the sum of squared deviations for the predicted Ocular Therapeutix price change compared to its average price change.About Ocular Therapeutix Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Ocular Therapeutix on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Ocular Therapeutix based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Ocular Therapeutix price pattern first instead of the macroeconomic environment surrounding Ocular Therapeutix. By analyzing Ocular Therapeutix's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Ocular Therapeutix's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Ocular Therapeutix specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 0.96 | 0.89 | 1.2 | 2.26 | Days Of Inventory On Hand | 103.55 | 158.7 | 159.31 | 201.23 |
Ocular Therapeutix November 30, 2024 Technical Indicators
Most technical analysis of Ocular help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Ocular from various momentum indicators to cycle indicators. When you analyze Ocular charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0561 | |||
| Market Risk Adjusted Performance | 2.14 | |||
| Mean Deviation | 2.67 | |||
| Semi Deviation | 2.92 | |||
| Downside Deviation | 3.14 | |||
| Coefficient Of Variation | 1585.31 | |||
| Standard Deviation | 3.54 | |||
| Variance | 12.5 | |||
| Information Ratio | 0.0242 | |||
| Jensen Alpha | 0.2002 | |||
| Total Risk Alpha | (0.38) | |||
| Sortino Ratio | 0.0272 | |||
| Treynor Ratio | 2.13 | |||
| Maximum Drawdown | 19.78 | |||
| Value At Risk | (5.33) | |||
| Potential Upside | 6.61 | |||
| Downside Variance | 9.85 | |||
| Semi Variance | 8.55 | |||
| Expected Short fall | (3.26) | |||
| Skewness | 0.465 | |||
| Kurtosis | 1.17 |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ocular Therapeutix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For more information on how to buy Ocular Stock please use our How to buy in Ocular Stock guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocular Therapeutix. If investors know Ocular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocular Therapeutix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.29) | Revenue Per Share 0.529 | Quarterly Revenue Growth 0.083 | Return On Assets (0.22) | Return On Equity (0.73) |
The market value of Ocular Therapeutix is measured differently than its book value, which is the value of Ocular that is recorded on the company's balance sheet. Investors also form their own opinion of Ocular Therapeutix's value that differs from its market value or its book value, called intrinsic value, which is Ocular Therapeutix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocular Therapeutix's market value can be influenced by many factors that don't directly affect Ocular Therapeutix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocular Therapeutix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocular Therapeutix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocular Therapeutix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.